Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (278)

2024

  1. Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up Outcomes

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 1, pp. 60-72

  2. Characterizing the “iceberg peak” in valvular heart disease: Outcomes and costs of in-hospital procedures in Spain

    REC: CardioClinics

  3. Determinants of Tricuspid Regurgitation Progression and Its Implications for Adequate Management

    JACC: Cardiovascular Imaging, Vol. 17, Núm. 6, pp. 579-591

  4. Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 12, pp. 1485-1495

  5. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation

    European heart journal, Vol. 45, Núm. 8, pp. 586-597

2023

  1. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study

    European Journal of Heart Failure, Vol. 25, Núm. 8, pp. 1352-1360

  2. Improving access to transcatheter aortic valve implantation across Europe by restructuring cardiovascular services: An expert council consensus statement

    Catheterization and Cardiovascular Interventions, Vol. 102, Núm. 3, pp. 547-557

  3. Right heart remodelling after bicaval TricValve implantation in patients with severe tricuspid regurgitation

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 5, pp. e450-e452

  4. Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation

    Heart, Vol. 109, Núm. 18, pp. 1401-1406

2022

  1. 6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 13, pp. 1366-1377

  2. Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry

    European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1253-1265

  3. Optimal surgical timing after post-infarction ventricular septal rupture

    Cardiology Journal, Vol. 29, Núm. 5, pp. 773-781

2021

  1. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

    Frontiers in Physiology, Vol. 12

  2. Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR

    New England Journal of Medicine, Vol. 385, Núm. 23, pp. 2150-2160

  3. New insights of tricuspid regurgitation: A large-scale prospective cohort study

    European Heart Journal Cardiovascular Imaging, Vol. 22, Núm. 2, pp. 196-202

2020

  1. Ischemia trial: Back to the future or forward to the past?

    Cardiology Journal

  2. Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164

2019

  1. Current status of anticoagulation in patients with breast cancer and atrial fibrillation

    Breast, Vol. 46, pp. 163-169

2018

  1. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis

    European Heart Journal, Vol. 39, Núm. 15, pp. 1224-1245

2017

  1. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement

    Journal of the American College of Cardiology, Vol. 69, Núm. 16, pp. 2067-2087